Thyroid eye disease is debilitating. It predominantly affects women and people with #GravesDisease. There are too many barriers to access current treatments. We have a clear opportunity to change that with support from @tpg’s The Rise Fund https://t.co/jAQqNkqTVN #autoimmune#TED
https://t.co/MxYJYHNLro
FCF is proud to launch FibroConnect!
It brings one-on-one mentorship support to individuals impacted by fibrolamellar liver cancer. FibroConnect aims to connect cancer fighters, survivors, caregivers and family members with experienced fibro mentors.
Opinion: If all oars are rowing in the same direction, we have a historic opportunity to move from recognition of health inequities to doing something meaningful about them. https://t.co/cXn9elmi9H
Just released w. my Harvard Medical School colleagues @DrSarahBallou & @drsarahNgray "The U.S. National Pandemic Emotional Impact Report", detailing our findings about the pandemic's emotional impact on the U.S. population. The report is downloadable at: https://t.co/xRblHZc34V
"A legal doctrine called 'qualified immunity' shields police and all other government officials from accountability for their illegal and unconstitutional acts," writes Patrick Jaicomo and Anya Bidwell of @ij for @usatodayopinion. https://t.co/nBcXArrAWS
"We must create a more egalitarian society out of the ashes by transforming policing. The blueprint was laid out in the 1960s — empowering low-income citizens to change their communities in their own vision..."
Read history prof @elizabhinton:
https://t.co/3YUDhM7UCY
Today we are announcing a $1 billion / 4-year commitment to support economic opportunity initiatives to combat racial inequality accelerated by the global pandemic. Read more: https://t.co/Xrl4W8KRsM
Set your alarm⏰ 9 states have primary elections on June 2nd. If you live in one of these states, are you ready to vote? Visit https://t.co/UZn3ZeGFFJ to:
👉check if you’re registered.
👉look up what races are on your ballot.
👉where to vote if you need to go in-person.
In honor of Clinical Trials Day on May 20, we salute the researchers 👩🔬 👨🔬 and participants 👭 👬 👫 who help make new medicines possible. #ThankYou to clinical trial participants everywhere. #ScienceWillWin#CTD2020
Today is #ClinicalTrialsDay & we want to thank everyone who makes this *critically important* #research happen - patients, families clinicians, researchers, institutions, industry...clinical trials = instrumental in finding new treatments / therapies for #fibrolamellar 🧬🦠🧫🔬
Thanks for @FibroFoundation support and contributions of #fibrolamellarconsortium founders @sloan_kettering @DanaFarber@UCSFCancer. A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Le… https://t.co/iaKDfE6sJL
Thanks for @FibroFoundation support and contributions of #fibrolamellarconsortium founders @sloan_kettering @DanaFarber@UCSFCancer. A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Le… https://t.co/iaKDfE6sJL